======= MTA1 ======= == Gene Information == * **Official Symbol**: MTA1 * **Official Name**: metastasis associated 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9112|9112]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13330|Q13330]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MTA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MTA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603526|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that was identified in a screen for genes expressed in metastatic cells, specifically, mammary adenocarcinoma cell lines. Expression of this gene has been correlated with the metastatic potential of at least two types of carcinomas although it is also expressed in many normal tissues. The role it plays in metastasis is unclear. It was initially thought to be the 70kD component of a nucleosome remodeling deacetylase complex, NuRD, but it is more likely that this component is a different but very similar protein. These two proteins are so closely related, though, that they share the same types of domains. These domains include two DNA binding domains, a dimerization domain, and a domain commonly found in proteins that methylate DNA. The profile and activity of this gene product suggest that it is involved in regulating transcription and that this may be accomplished by chromatin remodeling. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]. * **UniProt Summary**: Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator. As a part of the histone-deacetylase multiprotein complex (NuRD), regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA. In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A. Acts as a transcriptional coactivator of BCAS3, PAX5 and SUMO2, independent of the NuRD complex. Stimulates the expression of WNT1 by inhibiting the expression of its transcriptional corepressor SIX3. Regulates p53-dependent and -independent DNA repair processes following genotoxic stress. Regulates the stability and function of p53/TP53 by inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the p53-dependent DNA repair. Plays an important role in tumorigenesis, tumor invasion, and metastasis. Involved in the epigenetic regulation of ESR1 expression in breast cancer in a TFAP2C, IFI16 and HDAC4/5/6-dependent manner. Plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (LD) cycles. Positively regulates the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of its own transcription and the transcription of CRY1. Regulates deacetylation of ARNTL/BMAL1 by regulating SIRT1 expression, resulting in derepressing CRY1- mediated transcription repression. Isoform Short binds to ESR1 and sequesters it in the cytoplasm and enhances its non-genomic responses. With TFCP2L1, promotes establishment and maintenance of pluripotency in embryonic stem cells (ESCs) and inhibits endoderm differentiation (By similarity). {ECO:0000250|UniProtKB:Q8K4B0, ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:17671180, ECO:0000269|PubMed:17922032, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24413532}. |ELM2| |BAH| |GATA| |positive regulation of protein autoubiquitination| |regulation of protein autoubiquitination| |locomotor rhythm| |NuRD complex| |entrainment of circadian clock by photoperiod| |circadian behavior| |rhythmic behavior| |photoperiodism| |entrainment of circadian clock| |RNA polymerase II repressing transcription factor binding| |histone deacetylation| |protein deacetylation| |protein deacylation| |macromolecule deacylation| |circadian regulation of gene expression| |RNA polymerase II distal enhancer sequence-specific DNA binding| |histone deacetylase binding| |regulation of circadian rhythm| |positive regulation of protein ubiquitination| |positive regulation of protein modification by small protein conjugation or removal| |circadian rhythm| |response to ionizing radiation| |nuclear envelope| |double-strand break repair| |locomotory behavior| |regulation of protein ubiquitination| |regulation of protein modification by small protein conjugation or removal| |regulation of gene expression, epigenetic| |transcription corepressor activity| |rhythmic process| |transcription coactivator activity| |response to light stimulus| |microtubule| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |histone modification| |covalent chromatin modification| |chromatin binding| |response to radiation| |RNA polymerase II proximal promoter sequence-specific DNA binding| |DNA repair| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |behavior| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |intracellular membrane-bounded organelle| |chromatin organization| |DNA metabolic process| |cellular response to DNA damage stimulus| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |cellular macromolecule catabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-1.78| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.7| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|1.78| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|1.83| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.97| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.98| |[[:results:exp274|Citral 50μM R06 exp274]]|2.31| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.36| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.47| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4382 * **Expression level (log2 read counts)**: 6.98 {{:chemogenomics:nalm6 dist.png?nolink |}}